Best Novartis Podcasts (2024)

1
Novo Nordisk shares phase 2a obesity trial data, Achilles Therapeutics ends TIL-based therapy, Express Scripts sues FTC [The good, the bad, the ugly] 3:24

3h ago3:24

3:24

oin us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Novo Nordisk shares phase 2a trial data for obesity treatment The bad — Achilles Therapeutics to discontinue TIL-based therapy The ugly — Express Scripts files lawsuit against FTC…

1
Ep. 68 - Inside BeiGene: CEO John Oyler on Owning the Drug Development Process 35:08

6d ago35:08

35:08

Few CEOs have built a $20 billion biotech in under 15 years, as John Oyler has with BeiGene, managing to stay in that market cap band even through the downmarket. His strategy, to own clinical trials and manufacturing early on, looks particularly prescient in light of the cost and supply constraints threatening many biotechs today. On this episode …

1
[Solutions Spotlight] Optimizing contamination control in pharma facilities 12:32

2h ago12:32

12:32

Drugmakers face stringent regulations to ensure that products remain free from contaminants that could compromise safety and efficacy. Effective contamination control requires meticulous monitoring of environmental conditions, rigorous testing of products, and implementation of robust cleaning and sterilization procedures. To better understand thes…

1
Repairing Fragmented Care with Value-Based Strategies with Dr. Kamal Golla 46:51

2h ago46:51

46:51

🎙 ABOUT DR VISHNUKAMAL GOLLA Dr. Vishnukamal Golla is the medical director for value transformation at Evolent, a specialty and primary care management company. In this role, Dr. Golla leads the implementation of innovative value-based care models in specialty care. In helping Evolent manage approximately $1 billion of risk-based oncology and cardi…

1
Ep 233 "Q&A About Plaque Psoriasis" 35:54

3h ago35:54

35:54

Moderator Renee Joyce asks dermatologist Dr. James Song at Frontier Dermatology Partners for his response to questions from you, our listeners like: What triggers psoriasis and how to avoid it? Can diet help scalp psoriasis? How to treat psoriasis on the face, neck or in the mouth? What type of psoriasis makes you prone to PsA? What's Woronoff's ri…

1
Roche wins FDA approval for subcutaneous cancer immunotherapy, Moderna to cut $1.1B in R&D expenses, Teva settles $80M opioid case with Baltimore [The good, the bad, the ugly] 3:34

3d ago3:34

3:34

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Roche snags FDA nod for subcutaneous cancer immunotherapy The bad — Moderna to cut R&D expenses by $1.1B The ugly — Teva reaches $80M opioid settlement with Baltimore…

1
Looking Outside Brand Building: Oana Leonte, Founder unmtchd.brands 36:22

3d ago36:22

36:22

Today we’re looking outside a very familiar topic, exploring brand building that strengthens a brand’s equity today and sets it up for the future. We’re joined for this all-marketing chat with marketing rockstar, fellow podcaster, Founder of unmtchd.brands and former Puma exec, Oana Leonte. Oana recently pivoted from a marketing career working to b…

1
Pfizer, Valneva share phase 2 Lyme vax data, IN8bio axes workforce, AstraZeneca employees detained in China [The good, the bad, the ugly] 4:12

9d ago4:12

4:12

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer, Valneva share phase 2 positive Lyme vax data The bad — IN8bio axes workforce, halts trial The ugly — AstraZeneca employees detained in ChinaBy Pharma Manufacturing

1
Episode #23 - Ellen Donnelly (Partner, DG Advisors, New York, NY) 44:02

20d ago44:02

44:02

Tune in now to meet @Ellen Donnelly, Partner, DG Advisors in New York, NY Join us to celebrate Ellen's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Ellen's for being such an inspiring role model! It's Time To Launch Connections To Ignite Your Success! Are you Ready!!! Watc…

1
Ep 67 - AAM's Craig Burton on Opportunities, Challenges of U.S. Biosimilars Market 28:51

20d ago28:51

28:51

There is good news in this year’s Association for Accessible Medicines report on savings from biosimilars, including a 30% increase over the last year in savings attributed to biosimilars. The report also explores the economic, policy and regulatory headwinds that are preventing the industry from generating savings at a level that would have a dram…

1
FDA approves Illumina cancer biomarker test, BioMarin reveals more layoffs, FDA hits API maker Global Calcium with 483 [The good, the bad, the ugly] 3:30

10d ago3:30

3:30

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Illumina cancer biomarker test The bad — BioMarin reveals more layoffs The ugly — FDA hits API maker Global Calcium with 483By Pharma Manufacturing

1
Pharma’s new age of longevity 4:15

16d ago4:15

4:15

The concept of healthspan has recently gained new attention in the pharma industry and rightfully so, given the surprisingly large chasm in the U.S. between average years lived (77.5) and average years lived in good health (63.9). Facing a growing demographic of unhealthy seniors, a handful of innovative biotechs are reframing the longevity discuss…

1
Ep. 232 "Living with Generalized or Palmoplantar Pustular Psoriasis?" 33:58

17d ago33:58

33:58

Living with pustular psoriasis is tough. Hear the latest updates about heritable aspects of GPP, diagnosis, management tips, and treatment options such as the IL-36 inhibitor spesolimab, how it works and how effective it is from dermatologist Dr. Laura Ferris, Professor of Dermatology at the University of Pittsburgh and moderator Alan Simmons. This…

1
Episode #22 - Dr. Jim Strong (Provost and Vice President of Student Affairs (retired) - California State University - Stanislaus 35:35

29d ago35:35

35:35

Tune in now to meet @Jim Strong, Provost and Vice President for Academic Affairs (retired) and Professor of Marketing at California State University - Stanislaus. Join us to celebrate Jim's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Jim's for being such an inspiring role…

1
Emergent donates 50k doses of mpox vaccine to Africa, FDA rejects Regeneron blood cancer bispecific antibody, China indicts Astellas exec for espionage [The good, the bad, the ugly] 3:41

18d ago3:41

3:41

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Emergent donates 50,000 doses of mpox vaccine to Africa The bad — FDA rejects Regeneron blood cancer bispecific antibody The ugly — China indicts Astellas exec for espionage…

1
Popular Episode - Bob Nelsen on AI, China and the IRA 35:33

1M ago35:33

35:33

This is a previously recorded episode of The BioCentury Show from February 22, 2024. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes. In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited…

1
Ep. 231 "The 'PSConnection': Understanding the Potential Link Between Psoriasis and Psoriatic Arthritis" A Novartis-sponsored episode 27:41

26d ago27:41

27:41

Join NPF moderator LB Herbert as NPF patient volunteers Sam Blonien and Jeff Brown get candid about their experience living with psoriasis (PsO) and psoriatic arthritis (PsA). Hear from Sam and Jeff, along with commentary from Dr. Andrea Murina, on the potential connection between PsO and PsA, the importance of finding the right doctor, and where t…

1
FDA approves Ascendis drug, Lykos PTSD treatment rejected, Novartis bid blocked [The good, the bad, the ugly] 3:21

25d ago3:21

3:21

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Ascendis hypoparathyroidism drug The bad — FDA rejects Lykos MDMA PTSD drug The ugly — Judge blocks Novartis bid to stop generic blockbuster heart drug…

1
Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri 1:00:35

29d ago1:00:35

1:00:35

🎙ABOUT DR. ROBERT HARIRI: Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he s…

1
A journey to leadership: a chat with visionary leader and role model Raj Bhogal. 58:52

1M ago58:52

58:52

A journey to leadership; a chat with visionary global leader and role model Raj Bhogal, currently @Jazz Pharmaceuticals strategising and making things happen! This is a wonderful discussion highlighting how to drive forward your career and create opportunities for yourself. However, there is so much more that we cover in this episode and some of th…

1
Amneal's Parkinson's pill approved, Novo Nordisk withdraws Wegovy approval expansion bid, FDA delays BeiGene Tevimbra decision [The good, the bad, the ugly] 2:59

1M ago2:59

2:59

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Amneal gets FDA nod for Parkinson’s pill The bad — Novo Nordisk withdraws bid for Wegovy label expansion in heart failure The ugly — FDA delays decision on BeiGene Tevimbra as a first-line therapy…

1
Ep. 66 - Jane Grogan on Building Biogen’s Growth Engine 32:23

2M ago32:23

32:23

As Jane Grogan anticipates the unmet needs in patients five years from now, she’s harnessing a wave of interest in targeting B cells as a key driver of an immunology expansion at Biogen. In conversation with Editor in Chief Simone Fishburn on The BioCentury Show, Grogan, who became EVP and head of research of Biogen in October, discusses how she’s …

1
Driving Better Outcomes with Ambulatory Surgical Centers 54:26

2M ago54:26

54:26

ABOUT ARIC BURKE Aric brings over eighteen years of experience in ASC consulting, development, and operations. He oversees the strategic vision, operational management, and organizational structure of Atlas, driving its profitability and strategic direction. Before founding Atlas, Aric was the West Market President for United Surgical Partners Inte…

1
Looking Outside Insights BS: Ryan Barry, President Zappi 37:35

1M ago37:35

37:35

Today we’re taking a no BS look at the world of customer insights, leadership and business visioning with the President of software company Zappi, the ever-passionate and transparent leader, Ryan Barry. Having led Zappi for over four years, Ryan shares his no holds barred take on company leadership and people leadership, and it’s all anchored on au…

1
FDA approves Adaptimmune therapy, halts vTv diabetes program; Sanofi sues Sarepta over Duchenne patents [The good, the bad, the ugly] 3:58

1M ago3:58

3:58

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Adaptimmune engineered cell therapy The bad — FDA puts clinical hold on vTv Therapeutics diabetes program The ugly — Sanofi sues Sarepta over manufacturing patents for Duchenne gene ther…

1
Episode #21 - Dr. Jerry Jakubowski (Provost and VP Student Affairs (retired) at California Maritime Academy) 29:42

2M ago29:42

29:42

Tune in now to meet Dr. Jerry Jakubowski, Provost and Vice President for Academic Affairs (retired) at California Maritime Academy in Vallejo, CA. Join us to celebrate Jerry's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Jerry for being such an inspiring role model! It's T…

1
Ep 230 "Is My Psoriasis Flare Due to Medications I'm Taking?" 20:54

2M ago20:54

20:54

Is it possible your flare of psoriasis is due to products or medications you use? Learn what medications for high blood pressure, depression, anxiety, pain (NSAIDS), or infection can potentially flare psoriasis, and what paradoxical psoriasis is from Clinical Dermatology Pharmacist Lacey Glover, Pharm.D., University of Alabama Medicine, and moderat…

1
FDA approves Sun Pharma hair loss drug, FDA issues warning letter to Brassica, EMA rejects Eisai-Biogen Alzheimer's drug [The good, the bad, the ugly] 3:46

2M ago3:46

3:46

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Sun Pharma hair loss drug The bad — FDA issues harsh warning letter to Indian CDMO Brassica The ugly — EMA issues negative opinion on Eisai-Biogen Alzheimer's drug…

1
Ep. 65 - Astellas' Claus Zieler: Global Launches with Local Impact 32:27

2M ago32:27

32:27

As Astellas prepares to launch four products in parallel, Chief Commercial Officer Claus Zieler is balancing the complexity of this multi-faceted enterprise with a simple guiding principle: it has to work at a local level, and that will change with geography, circumstance and time. In conversation with Editor in Chief Simone Fishburn on The BioCent…

1
#134: Corey Mintz — Freelance Food Reporter for The New York Times, Eater and more, Hospitality Operations Advisor, author of ‘The Next Supper: The End of Dining as we Know It’ 26:36

2M ago26:36

26:36

2024 is going to be remembered for a lot of things, one of them being that it was the year we finally moved past the COVID-19 Pandemic. Industries everywhere are claiming to ‘be back’ to pre-pandemic functions, with everything from return to office initiatives to the National Restaurant Association boasting that restaurants are back to 2019 rates o…

1
Genentech's oral weight loss drug shows promise; FDA denies accelerated approval for Agenus' cancer drug; Orexo's opioid overdose drug rejected again [The good, the bad, the ugly] 3:35

2M ago3:35

3:35

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Genentech's oral weight loss drug shows promise The bad — FDA denies accelerated approval for Agenus' cancer drug The ugly — Orexo's opioid overdose drug rejected again…

1
Looking Outside Plant-Based Food: Marc Coloma, CEO Heura & Food Activist 44:03

2M ago44:03

44:03

In this episode, we’re taking a look outside the very familiar food industry and a closer look at the emerging sector of plant-based food, with food activist, entrepreneur, and CEO and Co-Founder of Heura, Marc Coloma. Marc’s mission to transform the food industry starts with his own company, which acts as a symbol for what is possible; investing i…

1
Ep 229 "Shining New Light on Phototherapy for Psoriasis: Results of the Light Treatment Effectiveness Study" 23:17

2M ago23:17

23:17

Hear results from the Light Treatment Effectiveness (LITE) Study comparing home vs office based phototherapy for psoriasis with renowned dermatologist Dr. Kristina Duffin, Chair, Dept. of Dermatology, University of Utah, as she discusses benefits, innovations, and barriers with Dr. Guy Eakin, NPF Chief Scientific & Medical Officer. The LITE Study i…

1
Pfizer advances obesity pill, FDA rejects Novo insulin, FTC releases PBM report [The good, the bad, the ugly] 3:28

2M ago3:28

3:28

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Pfizer advances once-daily obesity pill The bad — FDA rejects Novo Nordisk once-weekly insulin The ugly — FTC releases long-awaited report on PBMsBy Pharma Manufacturing

1
Ep. 64 - NPC CEO John O’Brien: Why America Needs an Honest Conversation About Drug Pricing 33:36

3M ago33:36

33:36

Ignorance about the path from scientific discovery to approved drugs, high out-of-pocket costs, and a byzantine healthcare system that obscures net prices while inflating list prices have fueled policies that threaten biomedical progress, John O’Brien, CEO of think tank National Pharmaceutical Council, told BioCentury. In an interview with The BioC…

1
Lilly Alzheimer’s drug gets full approval, Rocket gene therapy rejected, Eisai, BMS end ADC partnership [The good, the bad, the ugly] 3:44

2M ago3:44

3:44

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA grants Eli Lilly Alzheimer’s drug full approval The bad — FDA rejects Rocket gene therapy The ugly — Eisai, BMS end ADC partnershipBy Pharma Manufacturing

1
[Solutions Spotlight] Streamlining oral dose packaging design 31:57

3M ago31:57

31:57

By integrating a Quality by Design (QbD) approach, developers can design robust packaging from the outset, drastically reducing development time and costs. Understanding how moisture affects a product is key, allowing developers to use industry-accepted and validated models to predict and address potential stability issues early in the design phase…

1
Verona wins COPD nod, FDA rejects Merck-Daiichi ADC, Glenmark recalls potassium chloride capsules [The good, the bad, the ugly] 3:42

3M ago3:42

3:42

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Verona wins FDA nod for COPD The bad — FDA issues CRL to Merck-Daiichi lung cancer ADC The ugly — Glenmark recalls 114 batches of potassium chloride capsules…

1
Ep. 228 "A Future Free From Psoriatic Disease: The New NPF Strategic Plan" 30:39

3M ago30:39

30:39

Over the past year NPF has gathered insights from the psoriatic disease community to develop a new 5 year strategic plan. Join Matt Werbach, NPF Associate Director of Media and Communications as he speaks with NPF President and CEO Leah Howard, and Board Member Rick Seiden about the plan, milestones towards a cure, and steps to help improve the hea…

1
Episode #20 - Bill Yosses (Executive Chief and Former White House Pastry Chief, New York, NY) 36:52

3M ago36:52

36:52

Tune in now to meet Bill Yosses, Executive Chief in New York City. Bill has owned and operated restaurants in NYC and served as Executive Pastry Chief at The White under Presidents Bush and Obama. Join us to celebrate Bill's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Bil…

1
Ep. 63 - Day One's Jeremy Bender: Building Pediatric Oncology from the Ground Up 32:27

3M ago32:27

32:27

Pediatric cancer drug development is difficult: it requires high levels of safety, involves parents as well as the patients, and has small populations that can make it difficult to achieve the revenues that reward the investment. Squaring that circle, according to Day One Biopharmaceuticals CEO Jeremy Bender, is not impossible, but takes a dedicate…

1
#133: Amy Edmondson — Novartis Professor of Leadership and Management at the Harvard Business School, author of “Right Kind of Wrong: The Science of Failing Well” 27:21

3M ago27:21

27:21

For any long time listeners of the podcast, you know we are firm believers in failure being a positive thing. From D1 coaches to cutting edge researchers, great performers and leaders across the board understand the importance of allowing people to fail well. But, how exactly do you do that? Enter today’s guest Amy Edmondson, Novartis Professor of …

1
Looking Outside Imperfect Stories: Marco Andre, Head of Marketing & Gen AI, Novartis 40:22

3M ago40:22

40:22

In this episode of Looking Outside, we explore personal and professional growth from the angle of imperfection; not having it all figured out and embracing what you don’t know as a lever for learning. Even if you work for the world’s biggest and best brands. Just like our guest has done, Marco Andre, author of Imperfect Stories and Head of Marketin…

1
Gilead HIV shot delivers zero infections, Takeda epilepsy drug misses endpoints, Lilly goes after counterfeiters [The good, the bad, the ugly] 3:36

3M ago3:36

3:36

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Gilead twice-yearly HIV shot delivers zero infections in trial The bad — Takeda epilepsy drug misses endpoints in trials The ugly — Eli Lilly goes after counterfeiters…

1
Working with IDNs: The Pharma Perspective 1:12:50

3M ago1:12:50

1:12:50

ABOUT HEALTH CARE ROUNDS Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments. ABOUT MATT PORTCH Matt Portch is…

1
Episode #19 - Al Thigpen (Lead Operating Partner, Nautic Partners, Chicago, IL) 38:45

3M ago38:45

38:45

Tune in now to meet Al Thigpen, Lead Operating Partner for Nautic Partners in Chicago. He also serves as Chair of The Board of Directors for EmpiRX Health and is a board member of multiple other pharmaceutical and healthcare companies. Join us to celebrate Al's life journey and learn about the power of using The Threads of Connectivity to build you…

1
FDA backs Lilly Alzheimer’s drug; Pfizer Duchenne gene therapy fails; Talc plaintiffs seek J&J bankruptcy restraining order [The good, the bad, the ugly] 4:25

3M ago4:25

4:25

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA AdComm backs Eli Lilly Alzheimer’s drug The bad — Pfizer gene therapy fails phase 3 Duchenne trial The ugly — Talc plaintiffs seek restraining order on J&J bankruptcy tactic…

1
Ep 227 "Our Tips for Managing Psoriasis and Life Together" 37:30

3M ago37:30

37:30

Being a couple has its challenges. When do you let someone know you have psoriasis? What do you do to be a great partner? Hear Licensed Professional Counselor Mary Maraventano Stried chat with Lori and Howard Chang, who has had psoriasis for 45 years, about key ingredients to navigating life together for 30 years from acceptance, open communication…

1
Ep. 62 - Rick Bright: Navigating the Avian Flu Threat 40:22

3M ago40:22

40:22

The U.S. is experiencing events that are either the first stages of a widespread avian influenza outbreak or a fire drill that will show how well the nation is prepared for an outbreak. The U.S. has not stepped up to meet the challenge, Rick Bright, the former director of BARDA, told BioCentury. In an interview with The BioCentury Show's Steve Usdi…

1
Episode #18 - Roquel Cunningham Bush (Project Manager, Sequoia, Dallas, TX) 39:45

3M ago39:45

39:45

Tune in now to meet Roquel Cunningham Bush, Project Manager at Sequoia in Dallas, TX. Join us to celebrate Roquel's life journey and learn about the power of using The Threads of Connectivity to build your relationship network. Thank you Roquel for being such an inspiring role model! It's Time To Launch Connections To Ignite Your Success! Are you R…

Podcasts Worth a Listen

Novartis Podcasts

Podcasts Worth a Listen

Quick Reference Guide